Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Glioblastoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Drug Therapy, Combination × Clear all
NCT05908838 2023-06-18

Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer

ShuGuang Hospital

Phase EARLY_PHASE1 Completed
146 enrolled
Gastrointestinal

Disease, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡